載入...
Elevated Hexokinase II Expression Confers Acquired Resistance to 4-Hydroxytamoxifen in Breast Cancer Cells
Tamoxifen has been clinically used in treating estrogen receptor (ER)-positive breast cancer for over 30 years. The most challenging aspect associated with tamoxifen therapy is the development of resistance in initially responsive breast tumors. We applied a parallel-reaction monitoring (PRM)-based...
Na minha lista:
| 發表在: | Mol Cell Proteomics |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
The American Society for Biochemistry and Molecular Biology
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6823848/ https://ncbi.nlm.nih.gov/pubmed/31519767 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/mcp.RA119.001576 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|